Salt Lake City, Utah - Siemens Healthcare (booth #1021) addresses the need to minimize radiation exposure with the introduction of Iterative Reconstruction in Image Space (IRIS) CT technology for molecular imaging at the 2010 SNM Annual Meeting in Salt Lake City this week. By adding IRIS CT to the TrueV and HD technologies already available with Siemens Biograph family of PET-CT scanners, users can achieve more than 50 percent dose reduction, while doubling the scan speed of conventional PET/CT systems. At the same time, the first clinical results from IQ-SPECT will be showcased, acquired at double the scan speed of conventional SPECT imaging and with half the injected dose.

Two of the most challenging issues facing healthcare today are the dual mandates to improve patient safety and increase productivity. From a patient care and economic perspective, each is critically important. Siemens Molecular Imaging is meeting both of these core needs, at the same time, through its commitment: "Minimum Dose. Maximum Speed." Siemens offers innovative imaging solutions, where the lowest dose can be used, while still scanning patients faster than ever before. By reducing dose and increasing speed, costs are dramatically reduced, while increased utilization can also be achieved.

Symbia® IQ·SPECT technology enables routine scans using half dose and double speed. Another breakthrough innovation for low dose imaging is Iterative Reconstruction in Image Space (IRIS), which routinely achieves up to 60 percent additional CT dose reduction, while maintaining excellent image quality. By offering IRIS, TrueV and HD technologies on the Biograph mCT, Siemens is the only company that can provide routine PET/CT imaging using half dose and double speed.
"Enabling clinicians to maintain the highest level of image quality, while minimizing dose levels and increasing speed is an important part of our
responsibility to the industry. It is imperative that we find a way to offer our customers high-quality solutions, customizable to every patient need, while keeping exposure levels to a minimum," said Britta Fuenfstueck, chief executive officer, Molecular Imaging, Siemens Healthcare. "Molecular imaging is a valuable asset in the detection, staging and monitoring of disease, and Siemens is committed to minimizing radiation exposure without sacrificing image quality."

Siemens' commitment to delivering minimum dose and maximum speed enables high patient comfort and safety and increases utilization. Whether a patient is pediatric and needs a lower dose or geriatric and needs a faster scan, there is an applicable solution in every scanning situation.

More HCB News